Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07799610

Senior Center Medication Safety and Empowerment Curriculum

Team Alice's Medication Safety and Empowerment Curriculum (MedSEC) helps older adults and caregivers learn how to safely manage medications. Many seniors take multiple medications, which can lead to harmful side effects or unnecessary treatments. This program, developed at the University at Buffalo, will be offered at senior centers in Western New York. It includes two interactive sessions that teach participants how to recognize medication risks and talk with their doctors about safer options. The curriculum uses videos, group discussions, and hands-on tools to build confidence and knowledge. It follows the "4Ms" of Age-Friendly Health Systems: What Matters, Medication, Mentation, and Mobility. A "Train-the-Trainer" model will help senior center staff continue the program long-term. The goal is to reduce medication harm, improve communication with healthcare providers, and support healthy aging in the community.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Older Adults Behavior Caregiver Awareness Empowerment, Patient Health Behavior Health Literacy Knowledge Medication and Supplement Use Patient Acceptance of Health Care Patient Participation Treatment Adherence and Compliance

Age range

55 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University at Buffalo

Buffalo, New York, 142148033, United States

Location status: Recruiting

Location contact

Robert G Wahler, Doctor of Pharmacy

CONTACT

[email protected]

7166454777

Robert G Wahler, Doctor of Pharmacy

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 55 years of age and above
  • taking prescription medications

Carepartner Inclusion Criteria:

  • currently an informal or formal care partner for an eligible patient (regardless of whether they live with or near the patient)
  • aged 18 years of age and above

Exclusion criteria

  • Patients with cognitive impairment that prevents their self-management of medications.

Treatment and study plan

Team Alice Medication Safety and Empowerment Curriculum (MedSEC)

Other

A two-part interactive curriculum that will improve medication safety awareness and empower participants to engage in conversations with healthcare providers. The focus of this study will be to evaluate the impact of the MedSEC on patient/care-partner knowledge and medication management patient activation levels. A pre/post study that surveys older adults/caregivers pre-curriculum intervention and post-curriculum intervention, in addition to 6 months after program completion.

Primary outcomes

  1. Evaluate the impact of the MedSEC on patient/care-partner knowledge and activation levels in managing medications through the Patient Activation Measure (PAM)

    Time frame: Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.

    Study seeks to enhance patient and care-partner activation, reduce polypharmacy and the use of potentially inappropriate medications (PIMs), and improve shared decision-making through the Patient Activation Measure (PAM).

  2. Evaluate the impact of the MedSEC on patient/care-partner knowledge and activation levels in managing medications through the Revised Patient Attitudes Towards Deprescribing (rPATD) questionnaires.

    Time frame: Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.

    Study seeks to enhance patient and care-partner activation, reduce polypharmacy and the use of potentially inappropriate medications (PIMs), and improve shared decision-making through the Revised Patient Attitudes Towards Deprescirbing (rPATD) questionnaires.

Secondary outcomes

  1. Change from Baseline in participant understanding of medication safety risks at 6 Months.

    Time frame: Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.

    85% of participants will demonstrate an understanding of medication safety risks through pre- and post-program patient/caregiver questionnaires, including the Patient Activation Measure (PAM) and Revised Patient Attitudes to Deprescribing (rPATD). Additional questions pertaining to knowledge retention and actionability will be asked at 6 months.

  2. Participants will demonstrate knowledge of the 4Ms (Age-Friendly Health System) framework through pre/post/6 month follow up questionnaires.

    Time frame: Change from baseline, post-program assessment (immediately after program completion), and 6 months after program completion.

    By the end of the program, 80% of participants will demonstate knowledge of the 4Ms framework, measured by four questions related to the 4Ms and the Age-Friendly Health System taken prior to the program, immediately post-program, and 6 months after program completion.

  3. Change in patient engagement as measured by the Patient Activation Measure (PAM) from baseline to 6 months post program.

    Time frame: Change from baseline (Day 1), post-program assessment (immediately after educational session 2, Day 7), and 6 months after program completion.

    6 months post-program, 65% of participants will show improved patient engagement, as measured by the Patient Activation Measure (PAM) questionnaire.

  4. Change from baseline in the mean of medications after 6 months follow-up

    Time frame: Change from baseline and 6 months after program completion.

    Within 6 months of completing program, 50% of participants with polypharmacy will have reduced medication usage by 10%. (mean # of medications.)

Other outcomes

  1. Post-Survey to Measure Program Impact and Participant Satisfaction

    Time frame: Post curriculum session 2 (immediately after educational session 2, Day 7)

    A post-survey questionnaire (immediately after program completion) will be used to assess the program's educational value and determine its effectiveness in increasing medication safety knowledge, empowerment, and patient self-advocacy, as well as participant satisfaction.

Sponsors and collaborators

Lead sponsor

State University of New York at Buffalo

Other

Collaborators

  • Health Foundation for Western and Central New York

Registry information

Official study title

Team Alice Senior Center Medication Safety and Empowerment Curriculum

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Sep 2, 2026
Registry last updated
Sep 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.